Why the study?
Low-value cardiovascular care is common, costly, and potentially harmful, creating risks of avoidable complications from subsequent cascades of care.
This AHA scientific statement outlines the scope of low-value cardiovascular care and proposes multi-level solutions to achieve meaningful and equitable reductions in unnecessary tests and procedures.
Requires urgent multi-level interventions to curb overuse; extends evidence into actionable AHA guidance for equitable cardiovascular care.
Low-value health care services that provide little or no benefit to patients are common, potentially harmful, and costly. Nearly half of the patients in the United States will receive at least 1 low-value test or procedure annually, creating risk of avoidable complications from subsequent cascades of care and excess costs to patients and society. Reducing low-value care is of particular importance to cardiovascular health given the high prevalence and costs of cardiovascular disease in the United States. This scientific statement describes the current scope and impact of low-value cardiovascular care; reviews existing literature on patient-, clinician-, health system-, payer-, and policy-level interventions to reduce low-value care; proposes solutions to achieve meaningful and equitable reductions in low-value care; and suggests areas for future research priorities.
No takes yet. Share an insight, caveat, or question.
A 2022 study studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: